In The News :: ProMIS Neurosciences, Inc. (PMN)

Oct 5, 2022

The ALS Curveball, Part II

Oct 5, 2022

The ALS Curveball, Part I

Aug 2, 2022

New Collaborative Research Grant will Support the Development of a Vaccine for Misfolded Protein Diseases

Jul 18, 2022

A Tale of Tangles We Weave, Chapter 4

Jul 14, 2022

ProMIS rings Nasdaq closing bell, July 13, 2022

Mar 17, 2022

A Tale Of Tangles We Weave

Jan 11, 2022

Stimulating the Next Generation of AD Treatment

Oct 5, 2021

Funding boost expands MND research in our region

Nov 4, 2020

Aducanumab edges closer to Potential Approval: Next up, the Advisory Committee meeting

Sep 23, 2020

Aducanumab: On the Regulatory Home Stretch in the USA